"Cancer biomarker" trang 1 - tải miễn phí từ tailieunhanh
MicroRNAs as early detection biomarker in cancer

MicroRNAs as early detection biomarker in cancer
6    61    1
Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer

Response biomarkers: Re-envisioning the approach to tailoring drug therapy for cancer
11    55    1
Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer

Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer
15    41    1
Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort

Plasma hPG80 (Circulating Progastrin) as a Novel Prognostic Biomarker for early-stage breast cancer in a breast cancer cohort
9    2    1
Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer

Identification of ZBTB4 as an immunological biomarker that can inhibit the proliferation and invasion of pancreatic cancer
15    5    1
Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer

Metastasis-associated in colon cancer-1 and aldehyde dehydrogenase 1 are metastatic and prognostic biomarker for non-small cell lung cancer
8    44    1
Loss of circulating exosomal miR-92b is a novel biomarker of colorectal cancer at early stage

Loss of circulating exosomal miR-92b is a novel biomarker of colorectal cancer at early stage
7    62    0
Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: Results from mCRC biomarker study

Decreased mean platelet volume predicts poor prognosis in metastatic colorectal cancer patients treated with first-line chemotherapy: Results from mCRC biomarker study
7    45    1
ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer

ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer
13    68    1
Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9

Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9
11    60    1
Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer

Identification and clinical validation of NUSAP1 as a novel prognostic biomarker in ovarian cancer
15    26    1
RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers

RUNX1 is a promising prognostic biomarker and related to immune infiltrates of cancer-associated fibroblasts in human cancers
16    20    1
ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer

ARHGAP39 is a prognostic biomarker involved in immune infiltration in breast cancer
16    5    1
MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer

MAPK8IP2 is a potential prognostic biomarker and promote tumor progression in prostate cancer
18    1    1
Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer

Identification of CPT2 as a prognostic biomarker by integrating the metabolism-associated gene signature in colorectal cancer
12    1    1
Long- term survival of women with breast cancer in biomarker context

Long- term survival of women with breast cancer in biomarker context
11    89    0
CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: A companion study to the PePiTA trial

CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: A companion study to the PePiTA trial
7    57    0
Increased systemic zonula occludens 1 associated with inflammation and independent biomarker in patients with hepatocellular carcinoma

Increased systemic zonula occludens 1 associated with inflammation and independent biomarker in patients with hepatocellular carcinoma
10    42    2
Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studies

Computational identification of biomarker genes for lung cancer considering treatment and non-treatment studies
19    39    1
Opting for local region in SHOX2 promoter as a DNA methylation biomarker for lung cancer diagnosis

Opting for local region in SHOX2 promoter as a DNA methylation biomarker for lung cancer diagnosis
6    34    1